ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
ClearNote Health has raised $52.0M in total funding. The most recent round was Series D. The last funding was announced in May 2026.
ClearNote Health's investors include Mattias Westman, Pathology Asia Holdings, Stephen Quake, Sandy Weill.
ClearNote Health is headquartered in San Diego, United States.
ClearNote Health delivers epigenomic and big data approaches to reinvent non-invasive molecular diagnostic testing.
ClearNote Health is at the Series D stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ClearNote Health — Funding & Investors." VCBacked, May 27, 2026, https://www.vcbacked.co/company/clearnote-health. Accessed August 1, 2026.
VCBacked. (2026). ClearNote Health — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/clearnote-health
{{cite web |title=ClearNote Health — Funding & Investors |url=https://www.vcbacked.co/company/clearnote-health |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated